Graphic version of this page | Change how these pages look


HomeClinical supportPrescribing guidelines←ENT: Nausea /Vomitting and Vertigo Drugs

ENT: Nausea /Vomitting and Vertigo Drugs prescribing guideline

The anti-emetic guidelines are currently in the process of being updated. Please note the following Drug Safety Update: Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy.

https://www.gov.uk/drug-safety-update/ondansetron-small-increased-risk-of-oral-clefts-following-use-in-the-first-12-weeks-of-pregnancy

Key documents




Do you want to add this to your CPD record?






Did you find this page helpful?


How can we improve this page?


Please fill in your email address if you would like a response to your feedback.


Did you find this page helpful?*






© 2024

Website by Sitekit, body system icons designed by Freepik